JCI

JCI

Isolation Unit

Isolation Unit

Global Healthcare Excellence Award 2018

Global Healthcare Excellence Award 2018

Gastrosciences

Gastrosciences

TAVI

TAVI

Pulmonology

Pulmonology

Management of Cardiovascular Disease – (Update of Pharmacology) – Certification Course – for students

Management of Cardiovascular Disease – (Update of Pharmacology) – Certification Course

Course Directors :Dr. Urmil Shah / Dr. Satya Gupta / Dr. Vineet Sankhla / Dr. Vipul Kapoor / Dr. Tejas V. Patel
Date: September 17, 2017 (Sunday)
Duration : 1 day
Number of seats : 50
Venue : CIMS Auditorium

Program Overview:
This course gives an overview of the pharmacological agents commonly used in the diagnosis and treatment of cardiovascular disease. Brief treatment will also be given to non-cardiac medications used in cardiac patients and their potential interactions. Candidates will learn how the various drugs act, are classified, and employed in stable patients and those undergoing emergency procedures, electrophysiological studies, catheterization, and other diagnostic studies. Special emphasis would be on commonly used emergency cardiac medicines and their adequate uses. Drug classes examined include thrombolytic, anticoagulant,antiarrhythmic, antianginal, antihypertensive, diuretic, lipid lowering and anti-arrhythmic drugs.

Program Highlights:

  • All about antiplatelets and anticoagulants
  • B-blockers & ACEI-Which one to choose?
  • Pharmoco invasive therapy for STEMI
  • Cholesterol lowering agents – Beyond statin – PCSK inhibition
  • Antihypertensive agents
  • Life saving drugs (Dopamine dobutamine noradrenaline)
  • Nuts and bolts of cardiovascular pharmacology
  • Use of antiarrhythmic drugs
  • Top 10 dietary supplements you need to know
  • Point of care applications to guide pharmacotherapy
  • Anticoagulation: To INR or not to INR
  • Anticoagulation cases
  • Polypharmacy in cardiovascular disease -how to impact compliance
  • Top 10 drugs/drug interactions
  • New oral anticoagulants for atrial fibrillation:controversies in drug selection, complications and cardioversion
  • NOACs are going to replace Warfarin as anticoagulant treatment of choice for NVAF

Management of Cardiovascular Disease - (Update of Pharmacology) - Certification Course

Registration Fees:  250/- (Non Refundable)
Spot Registration Fees :500/- (Non Refundable)

 Certificate of attendance will be given at the end of the Internship